The main risk is not whether Rocket Lab has a real business; it clearly does. The main risk is sequencing:
Neutron must clear qualification, launch successfully, and then convert
backlog into profitable revenue before today’s valuation demands overwhelm the equity case. That makes execution, capital discipline, and trust preservation more important than raw demand.